PDL BioPharma to Hold Annual Meeting of Stockholders on June 5, 2012
INCLINE VILLAGE, Nev., April 12, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will hold its annual meeting of stockholders on Tuesday, June 5, 2012, at 10:00 a.m. Pacific Time for all stockholders of record on April 13, 2012. The meeting will take place at the Hyatt Regency Hotel in Incline Village, Nevada.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
More by this Source
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
Dec 04, 2013, 16:02 ET
PDL BioPharma to Present at the 25th Annual Piper Jaffray Healthcare Conference
Dec 02, 2013, 11:46 ET
PDL BioPharma to Present at Upcoming Investor Conferences
Nov 07, 2013, 07:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.